12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

Helix financial update

Helix BioPharma will voluntarily delist its shares from NYSE MKT. The company, which will continue to trade on...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >